Novartis Foundation Launches New Leprosy Strategy at Symposium on Disease Elimination
Today's symposium of the Novartis Foundation for Sustainable Development (NFSD) convenes experts to discuss "What does it take to eliminate a disease?" Drawing lessons from previous successful disease control programmes, the symposium speakers discuss innovative approaches and advocate for new co-ordination strategies in disease elimination efforts.
The Novartis Foundation for Sustainable Development today also announces the launch of a new leprosy strategy based on the consensus reached by a group of leading experts earlier this year. The new strategy focuses on interrupting leprosy transmission through early diagnosis and treatment, contact tracing of former patients, diagnostic tools and strict surveillance and response.
"As part of our pledge to fight neglected diseases in the developing world, Novartis and the Novartis Foundation for Sustainable Development are committed to going the last mile to help make leprosy history," says Joseph Jimenez, CEO of Novartis, in an address to the symposium today. "This devastating disease is curable and I am proud that our donation of multidrug therapy (MDT) has helped treat more than five million patients since 2000."
Thanks to the availability of MDT, according to the World Health Organization (WHO), more than 15 million patients have been cured of leprosy since 1981, shrinking the worldwide prevalence by approximately 95%. During the past 8 years, however, the number of newly diagnosed leprosy patients has plateaued at around 230,000 cases per year. As experience with other disease control programmes has shown, going the last mile is often the hardest. Waning knowledge means that as prevalence decreases, so do political will and funding.
"The key to eradicating smallpox was a comprehensive approach including the availability of an effective, heat stable vaccine, epidemiological surveillance, thorough research, involvement of local communities, as well as strong management and commitment by the respective governments," says Professor Donald Henderson, former Head of the WHO's Smallpox Eradication Campaign. "Current elimination programs can also draw on these lessons learned."
CThe Novartis Foundation plans to take steps to demonstrate the feasibility and efficacy of this strategy in several sites in Asia, Africa and Latin America. "Zero transmission of leprosy is achievable, but we need to be better equipped and use innovative approaches if we are to find and treat the last patients," says Ann Aerts, Head of the Novartis Foundation. "In collaboration with our partners, we want to play a key role in curbing the incidence of leprosy."
Related News
-
News Pharmapack Awards 2024 Patient-Centric Design Award Winner – Dr Ferrer BioPharma
The 2024 Pharmapack Awards celebrated the best in innovation and design for the pharmaceutical packaging and drug delivery industry on January 24, 2024. -
News Women in Pharma: Minding the Gap at Pharmapack 2024
2024 marks the first year Pharmapack will host a Diversity track dedicated to bridging the gap within the pharmaceutical packaging and drug delivery sector. The track includes a panel discussion on 'Enabling Diversity in the Workplace,' focused... -
News Pharmapack Awards 2024 - Celebrating Packaging and Drug Delivery Innovation
The 2024 Pharmapack Innovation Awards ceremony celebrated the best in pharmaceutical packaging and drug delivery innovation at all levels. The awards were held on January 24, 2024 at the Paris Expo Porte de Versailles. -
News Pharmapack 2024 - From the Floor
Paris once again welcomes Europe’s leading trade show in pharmaceutical packaging and drug delivery innovation. Join our content team as Pharmapack 2024 opens its doors to leading experts and innovators in pharmaceutical packaging and drug delive... -
News CPHI Barcelona 2023: Partnering for Success – Managing Outsourcing Relationships to Optimise Manufacturing Operations
During CPHI Barcelona 2023, insightful content sessions offered attendees the chance to explore trending topics with expert speakers and panellists. Here, we summarise what the pharma industry and supply chain are talking about the most. -
News CPHI Barcelona 2023: Loading Potential – Artificial Intelligence for Pharma Manufacturing
During CPHI Barcelona 2023, insightful content sessions offered attendees the chance to explore trending topics with expert speakers and panellists. Here, we summarise what the pharma industry and supply chain are talking about the most. -
News Pharmaceutical industry supports COP28 health stance in joint statement
As COP28 takes place over this week in Dubai, UAE, several bodies in the pharmaceutical and health industries have come together to announce support of key movements in sustainability in the sector, and to recognise sustainability as a health issue.&nb... -
News CPHI Podcast Series: Start-ups take centre stage at CPHI Barcelona
The first episode of the CPHI Podcast Series since we attended CPHI Barcelona in October covers the Start-up market at the event, with expert Matthew Wise joining Editor Lucy Chard to discuss the event.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance